Green Cross Holdings
KRX:005250

Watchlist Manager
Green Cross Holdings Logo
Green Cross Holdings
KRX:005250
Watchlist
Price: 15 340 KRW 1.12%
Market Cap: ₩734.3B

Operating Margin

0.8%
Current
Improving
by 0.2%
vs 3-y average of 0.5%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
0.8%
=
Operating Income
₩18.2B
/
Revenue
₩2.4T

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
0.8%
=
Operating Income
₩18.2B
/
Revenue
₩2.4T

Peer Comparison

Country Company Market Cap Operating
Margin
KR
Green Cross Holdings
KRX:005250
696.5B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
389.3B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.3B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
170.5B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.2B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.1B USD
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
NL
argenx SE
XBRU:ARGX
42.4B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.4B USD
Loading...

Market Distribution

In line with most companies in Korea
Percentile
39th
Based on 2 615 companies
39th percentile
0.8%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

Green Cross Holdings
Glance View

Market Cap
734.3B KRW
Industry
Biotechnology

Green Cross Holdings Corp. is a holding company of Green Cross Corp. that engages in the manufacture of pharmaceutical products. The company is headquartered in Yongin, Gyeonggi-Do. The Company’s products portfolio consists of prescription drugs, blood derivatives, vaccines, cerebrovascular disease treatment, hunter syndrome drugs, as well as over the counter (OTC) drugs, such as skin disease treatment drugs, allergic cream and others. Its products are used for analgesic, treatment of cerebral thrombosis, hypoalbuminemia, genodermatosis and others, as well as prevention of influenza, prophylaxis of varicella, among others. The firm is also involved in the real estate sales and leasing, as well as construction business.

Green Cross Holdings Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
0.8%
=
Operating Income
₩18.2B
/
Revenue
₩2.4T
What is Green Cross Holdings's current Operating Margin?

The current Operating Margin for Green Cross Holdings is 0.8%, which is above its 3-year median of 0.5%.

How has Operating Margin changed over time?

Over the last 3 years, Green Cross Holdings’s Operating Margin has decreased from 4.2% to 0.8%. During this period, it reached a low of -1% on Mar 31, 2024 and a high of 4.2% on Sep 30, 2022.

Back to Top